GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OCSE:ALK B) » Definitions » Long-Term Capital Lease Obligation

Alk-Abello AS (OCSE:ALK B) Long-Term Capital Lease Obligation : kr267 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Alk-Abello AS Long-Term Capital Lease Obligation?

Alk-Abello AS's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was kr267 Mil.

Alk-Abello AS's quarterly Long-Term Capital Lease Obligation increased from Dec. 2023 (kr255 Mil) to Mar. 2024 (kr271 Mil) but then declined from Mar. 2024 (kr271 Mil) to Jun. 2024 (kr267 Mil).

Alk-Abello AS's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (kr207 Mil) to Dec. 2022 (kr226 Mil) and increased from Dec. 2022 (kr226 Mil) to Dec. 2023 (kr255 Mil).


Alk-Abello AS Long-Term Capital Lease Obligation Historical Data

The historical data trend for Alk-Abello AS's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Long-Term Capital Lease Obligation Chart

Alk-Abello AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 234.00 207.00 207.00 226.00 255.00

Alk-Abello AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 227.00 259.00 255.00 271.00 267.00

Alk-Abello AS  (OCSE:ALK B) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Alk-Abello AS Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello AS Business Description

Industry
Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello AS Headlines

No Headlines